“I've always thought it would settle out to $15-
Post# of 148110
(Total Views: 520)
Posted On: 02/28/2021 11:58:13 AM
“I've always thought it would settle out to $15-$20 just based on COVID approval.”
This number is very reasonable. By comparison, Novavax’s market cap is very roughly 4X 2021 projected revenue. I understand our revenue to earnings ratio will differ, but the most sensitive variable for us is what revenue will be. 3B - 4B in revenue at 4X hits this number. That said, NP has thrown out revenue numbers 2 - 3 times that - I am much less sanguine.
Read More: https://investorshangout.com/post/newpost/605...z6nmkZYcjG
This number is very reasonable. By comparison, Novavax’s market cap is very roughly 4X 2021 projected revenue. I understand our revenue to earnings ratio will differ, but the most sensitive variable for us is what revenue will be. 3B - 4B in revenue at 4X hits this number. That said, NP has thrown out revenue numbers 2 - 3 times that - I am much less sanguine.
Read More: https://investorshangout.com/post/newpost/605...z6nmkZYcjG
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼